METHOXSALEN
Substance profile for UNII U4VJ29L7BQ, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 4114Substance Identity#
- UNII
- U4VJ29L7BQ
- Preferred term
- METHOXSALEN
- Registry number
- 298-81-7
- EC number
- 206-066-9
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C12H8O4
Structure render from PubChem CID 4114Chemical And Database Identifiers#
- InChIKey
- QXKHYNVANLEOEG-UHFFFAOYSA-N
- SMILES
- COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
- RxCUI
- 6854
- PubChem
- 4114
- NCIt
- C643
- INN ID
- 0
DailyMed Socrata Ingredients#
Type, DailyMed label, SPL version table| Type | DailyMed label | SPL version |
|---|
| ACTIVE MOIETY | OXSORALEN-ULTRA (METHOXSALEN) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 5 |
| ACTIVE INGREDIENT | OXSORALEN-ULTRA (METHOXSALEN) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 5 |
| ACTIVE MOIETY | UVADEX (METHOXSALEN) INJECTION, SOLUTION [THERAKOS, INC.] | 5 |
| ACTIVE INGREDIENT | UVADEX (METHOXSALEN) INJECTION, SOLUTION [THERAKOS, INC.] | 5 |
| ACTIVE MOIETY | 8-MOP (METHOXSALEN) CAPSULE, GELATIN COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 4 |
| ACTIVE INGREDIENT | 8-MOP (METHOXSALEN) CAPSULE, GELATIN COATED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 4 |
| ACTIVE MOIETY | METHOXSALEN CAPSULE, LIQUID FILLED [ACTAVIS PHARMA, INC.] | 4 |
| ACTIVE INGREDIENT | METHOXSALEN CAPSULE, LIQUID FILLED [ACTAVIS PHARMA, INC.] | 4 |
| ACTIVE INGREDIENT | METHOXSALEN CAPSULE, LIQUID FILLED [STRIDES ARCOLAB LIMITED] | 3 |
| ACTIVE MOIETY | METHOXSALEN CAPSULE, LIQUID FILLED [STRIDES ARCOLAB LIMITED] | 3 |
| ACTIVE INGREDIENT | OXSORALEN (METHOXSALEN) LOTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 3 |
| ACTIVE MOIETY | OXSORALEN (METHOXSALEN) LOTION [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 3 |
| ACTIVE INGREDIENT | METHOXSALEN CAPSULE, LIQUID FILLED [OCEANSIDE PHARMACEUTICALS] | 2 |
| ACTIVE MOIETY | METHOXSALEN CAPSULE, LIQUID FILLED [OCEANSIDE PHARMACEUTICALS] | 2 |